BioSante Pharmaceuticals (BPAX) enters a merger deal with ANI Pharmaceuticals in an all-stock deal with BPAX as the surviving company. Former BPAX shareholders will own ~47%. Shares halted.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs